Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.62 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.60 |
| ▸ | DRD4 | P21917 | 2/20 | 0.60 |
| ▸ | DRD3 | P35462 | 2/20 | 0.60 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.60 |
| ▸ | HTR1A | P08908 | 1/20 | 0.60 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.60 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.60 |
| ▸ | HTR2C | P28335 | 1/20 | 0.60 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.60 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.60 |
| ▸ | HTR2B | P41595 | 1/20 | 0.60 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.60 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.60 |
| ▸ | DHCR7 | Q9UBM7 | 1/20 | 0.60 |
| ▸ | DRD1 | P21728 | 1/20 | 0.59 |
| ▸ | DRD5 | P21918 | 1/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.59 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.56 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11466104 | 0.92 | KCNH2 (0.68) | SIGMAR1DRD4DRD3HTR1AHTR2C | |
| Hydrochloric Acid SCHEMBL9852467 | 0.91 | GRIN1 (0.60) | SIGMAR1DRD4DRD3CHRM2HTR1A | |
| SCHEMBL8789784 | 0.87 | ABCB1 (0.63) | ABCB1SIGMAR1SLC6A3DHCR7DRD1 | |
| SCHEMBL31174290 | 0.87 | DHCR7 (0.60) | ABCB1SIGMAR1DRD4DRD3CHRM2 | |
| SCHEMBL9852537 | 0.85 | GRIN1 (0.62) | SIGMAR1DRD4DRD3CHRM2HTR1A | |
| SCHEMBL8506973 | 0.84 | ABCB1 (0.71) | ABCB1SIGMAR1DRD4DRD3CHRM2 | |
| SCHEMBL13896162 | 0.84 | ABCB1 (0.73) | ABCB1DHCR7 | |
| Hydrochloric Acid SCHEMBL9852474 | 0.83 | ABCB1 (0.61) | ABCB1SIGMAR1DRD4DRD3CHRM2 | |
| SCHEMBL28992946 | 0.83 | ABCB1 (0.55) | ABCB1DRD3SLC6A3DHCR7DRD1 | |
| SCHEMBL8790326 | 0.82 | KCNJ1 (0.67) | ABCB1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11505529-B2 | 8-phenyl-isoquinolines and pharmaceutical composition thereof used in the treatment of irritable bowel syndrome | NATIONAL TAIWAN UNIVERSITY (TW) | 2022-11-22 | — | — | US | disclosed |
| EP-1045843-A4 | INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE | MERCK & CO INC (US) | 2001-10-24 | — | — | EP | disclosed |
| EP-1045843-A1 | INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE | Merck & Co., Inc. (US) | 2000-10-25 | — | — | EP | disclosed |
| US-5977134-A | Inhibitors of farnesyl-protein transferase | MERCK & CO., INC. (US) | 1999-11-02 | — | — | US | disclosed |
| WO-1999028313-A1 | INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE | MERCK & CO., INC. (US) | 1999-06-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11505529-B2 | 8-phenyl-isoquinolines and pharmaceutical composition thereof used in the treatment of irritable bowel syndrome | HTR7, GPR27, HTR5A | ABCB1 328/4885SIGMAR1 252/4885DRD4 1156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.